Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Bladder Cancer

  Free Subscription


Articles published in Curr Opin Urol

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    July 2020
  1. GUST KM, Rebhan K, Resch I, Shariat SF, et al
    Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer.
    Curr Opin Urol. 2020;30:547-556.
    PubMed     Abstract available


    May 2020
  2. SORIA F, Giordano A, Shariat SF, Gontero P, et al
    Bladder sparing landscape for bacillus Calmette-Guerin unresponsive bladder cancer.
    Curr Opin Urol. 2020 May 13. doi: 10.1097/MOU.0000000000000789.
    PubMed     Abstract available


    April 2020
  3. SARI MOTLAGH R, Pradere B, Mori K, Miura N, et al
    Bladder-preserving strategies for Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?
    Curr Opin Urol. 2020 Apr 16. doi: 10.1097/MOU.0000000000000769.
    PubMed     Abstract available


    March 2020
  4. FABA OR, Palou J
    Emerging approaches and future perspectives in nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000766.
    PubMed    


  5. SUNG HH, Lerner SP
    Utility of lymphadenectomy in bladder cancer: where do we stand?
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000750.
    PubMed     Abstract available


  6. CIPOLLARI S, Carnicelli G, Bicchetti M, Campa R, et al
    Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Curr Opin Urol. 2020 Mar 9. doi: 10.1097/MOU.0000000000000743.
    PubMed     Abstract available


  7. LENFANT L, Aminsharifi A, Seisen T, Roupret M, et al
    Current status and future directions of the use of novel immunotherapeutic agents in bladder cancer.
    Curr Opin Urol. 2020 Mar 5. doi: 10.1097/MOU.0000000000000740.
    PubMed     Abstract available



  8. Bacillus Calmette-Guerin (BCG) treatment of bladder cancer: a systematic review and commentary on recent publications: Erratum.
    Curr Opin Urol. 2020;30:281.
    PubMed    


    February 2020
  9. FANKHAUSER CD, Teoh JY, Mostafid H
    Treatment options and results of adjuvant treatment in nonmuscle-invasive bladder cancer (NMIBC) during the Bacillus Calmette-Guerin shortage.
    Curr Opin Urol. 2020 Feb 25. doi: 10.1097/MOU.0000000000000739.
    PubMed     Abstract available


  10. WITJES JA
    Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn the last 24 months: a critical review.
    Curr Opin Urol. 2020 Feb 25. doi: 10.1097/MOU.0000000000000741.
    PubMed     Abstract available


    November 2019
  11. MORI K, D'Andrea D, Enikeev DV, Egawa S, et al
    En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.
    Curr Opin Urol. 2019 Nov 12. doi: 10.1097/MOU.0000000000000697.
    PubMed     Abstract available


    July 2019
  12. SADIGHIAN M, Porten S
    Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion.
    Curr Opin Urol. 2019 Jul 15. doi: 10.1097/MOU.0000000000000660.
    PubMed     Abstract available


  13. SATYAL U, Sikder RK, McConkey D, Plimack ER, et al
    Clinical implications of molecular subtyping in bladder cancer.
    Curr Opin Urol. 2019;29:350-356.
    PubMed     Abstract available


    May 2019
  14. POZO C, Shariat SF, D'Andrea D, Fajkovic H, et al
    Enhanced Recovery after Radical Cystectomy.
    Curr Opin Urol. 2019;29:227-238.
    PubMed     Abstract available


  15. BURG ML, Daneshmand S
    Frailty and preoperative risk assessment before radical cystectomy.
    Curr Opin Urol. 2019;29:216-219.
    PubMed     Abstract available


  16. HASSLER MR, Shariat SF, Soria F
    Salvage therapeutic strategies for bacillus Calmette-Guerin failure.
    Curr Opin Urol. 2019;29:239-246.
    PubMed     Abstract available


  17. CACCIAMANI GE, Rajarubendra N, Artibani W, Gill IS, et al
    Robotic intracorporeal urinary diversion: state of the art.
    Curr Opin Urol. 2019;29:293-300.
    PubMed     Abstract available


    March 2019
  18. JANISCH F, Shariat SF, Schernhammer E, Rink M, et al
    The interaction of gender and smoking on bladder cancer risks.
    Curr Opin Urol. 2019 Mar 14. doi: 10.1097/MOU.0000000000000602.
    PubMed     Abstract available


  19. MUN DH, Kimura S, Shariat SF, Abufaraj M, et al
    The impact of gender on oncologic outcomes of bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000606.
    PubMed     Abstract available


  20. EULITT PJ, Bjurlin MA, Milowsky MI
    Perioperative systemic therapy for bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000600.
    PubMed     Abstract available


  21. SMELSER WW, Woolbright BL, Taylor JA 3rd
    Molecular subtyping of bladder cancer: current trends and future directions in 2019.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000599.
    PubMed     Abstract available


  22. PHAM A, Ballas LK
    Trimodality therapy for bladder cancer: modern management and future directions.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000601.
    PubMed     Abstract available


  23. BHAT A, Ritch CR
    Urinary biomarkers in bladder cancer: where do we stand?
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000605.
    PubMed     Abstract available


    February 2019
  24. NASER-TAVAKOLIAN A, Ghodoussipour S, Djaladat H
    Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000598.
    PubMed     Abstract available


  25. MUKHERJEE N, Wheeler KM, Svatek RS
    Bacillus Calmette-Guerin treatment of bladder cancer: a systematic review and commentary on recent publications.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000595.
    PubMed     Abstract available


    January 2019
  26. BANDINI M, Fossati N, Briganti A
    Nomograms in urologic oncology, advantages and disadvantages.
    Curr Opin Urol. 2019;29:42-51.
    PubMed     Abstract available


    September 2018
  27. BRUCHBACHER A, Soria F, Hassler M, Shariat SF, et al
    Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?
    Curr Opin Urol. 2018 Sep 3. doi: 10.1097/MOU.0000000000000546.
    PubMed     Abstract available


    August 2018
  28. SORIA F, D'Andrea D, Pohar K, Shariat SF, et al
    Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice?
    Curr Opin Urol. 2018 Aug 27. doi: 10.1097/MOU.0000000000000545.
    PubMed     Abstract available


  29. MANNAS MP, Lee T, Nykopp TK, Costa JBD, et al
    A risk-stratified approach to the management of high-grade T1 bladder cancer.
    Curr Opin Urol. 2018 Aug 24. doi: 10.1097/MOU.0000000000000548.
    PubMed     Abstract available


  30. DYRSKJOT L, Ingersoll MA
    Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology.
    Curr Opin Urol. 2018 Aug 21. doi: 10.1097/MOU.0000000000000543.
    PubMed     Abstract available


  31. SCHRAML J, Silva JDC, Babjuk M
    Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection.
    Curr Opin Urol. 2018 Aug 9. doi: 10.1097/MOU.0000000000000542.
    PubMed     Abstract available


    March 2018
  32. DASON S, Goh AC
    Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions.
    Curr Opin Urol. 2018;28:115-122.
    PubMed     Abstract available


    January 2018
  33. FANKHAUSER CD, Mostafid H
    Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.
    Curr Opin Urol. 2018;28:88-92.
    PubMed     Abstract available


    October 2017
  34. MARI A, Abufaraj M, Gust KM, Shariat SF, et al
    Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature.
    Curr Opin Urol. 2017 Oct 17. doi: 10.1097/MOU.0000000000000459.
    PubMed     Abstract available


  35. SORIA F, Marra G, Capoun O, Soukup V, et al
    Prevention of bladder cancer incidence and recurrence: tobacco use.
    Curr Opin Urol. 2017 Oct 3. doi: 10.1097/MOU.0000000000000453.
    PubMed     Abstract available


    June 2017
  36. GILD P, Ehdaie B, Kluth LA
    Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival.
    Curr Opin Urol. 2017 Jun 24. doi: 10.1097/MOU.0000000000000425.
    PubMed     Abstract available


    December 2016
  37. HERRMANN TR, Wolters M, Kramer MW
    Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype.
    Curr Opin Urol. 2016 Dec 28. doi: 10.1097/MOU.0000000000000377.
    PubMed     Abstract available


  38. LIEM EI, de Reijke TM
    Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
    Curr Opin Urol. 2016.
    PubMed     Abstract available


    May 2016
  39. SELTZ LM, Herrell SD
    Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Curr Opin Urol. 2016;26:259-63.
    PubMed     Abstract available


    January 2016
  40. CHOPRA S, Abreu AL, Gill IS
    Robotic urinary diversion: the range of options.
    Curr Opin Urol. 2016;26:107-13.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: